Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Matteo Zignol, Marta Peracchi, Gloria Tridello...
https://pubmed.ncbi.nlm.nih.gov/15274078/Actively Recruiting
Led by Children's Hospital of Fudan University · Updated on 2025-06-27
174
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are investigating the antibody protection and immune memory after vaccination in children with Kaposiform Hemangioendothelioma KHE who are receiving sirolimus treatment. The study aims to explore the safety and effectiveness of timely vaccinations during sirolimus administration and to find alternative vaccination plans for KHE patients on sirolimus who do not respond to primary vaccinations. KHE mainly affects infants and young children under 1 year old, with a significant portion being neonates. Sirolimus suppresses the immune system, often leading to paused vaccinations and leaving children vulnerable to infections. The study addresses concerns about live vaccines causing severe infections and the loss of immune memory commonly seen in patients receiving immunosuppressive treatments.
CONDITIONS
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
K
Kai Li, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Hospital of Fudan University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 day
Participants undergo immunoglobulin and flow cytometry tests, outpatient evaluation, and assessment before vaccination.
1 visit (in-person)
Duration - 18 months
Participants receive vaccinations as advised and have antibody levels measured to assess immune response over time.
Visits at admission and at 7, 12, and 18 months after admission
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Matteo Zignol, Marta Peracchi, Gloria Tridello...
https://pubmed.ncbi.nlm.nih.gov/15274078/Shanie Saghafian-Hedengren, Ismael Söderström, Eva Sverremark-Ekström...
https://pubmed.ncbi.nlm.nih.gov/28886882/Yoshihiko Kawano, Michio Suzuki, Jun-ichi Kawada...
https://pubmed.ncbi.nlm.nih.gov/25665961/Lindy Zhang, Clifton P Thornton, Kathy Ruble...
https://pubmed.ncbi.nlm.nih.gov/32423345/Takeshi Inoue, Imogen Moran, Ryo Shinnakasu...
https://pubmed.ncbi.nlm.nih.gov/29664566/Jie Zhang, Fenglong Xie, Elizabeth Delzell...
https://pubmed.ncbi.nlm.nih.gov/22760290/Felix Horns, Cornelia L Dekker, Stephen R Quake
https://pubmed.ncbi.nlm.nih.gov/31968262/Peter Vink, Josep Maria Ramon Torrell, Ana Sanchez Fructuoso...
https://pubmed.ncbi.nlm.nih.gov/30843046/Hyo Jin Kwon, Jae-Wook Lee, Nak-Gyun Chung...
https://pubmed.ncbi.nlm.nih.gov/22219618/Guglielmo Dini, Alessandra Toletone, Ilaria Barberis...
https://pubmed.ncbi.nlm.nih.gov/27925503/Children's Hospital of Fudan University
Lead Sponsor